Sign up to save your podcasts
Or
Share Episode 31: T2DM treatment, T2DM with CVD or CKD, and pre-diabetes
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 31: T2DM treatment, T2DM with CVD or CKD, and pre-diabetes
A whole lotta diabetes goin' on: linagliptin ($780) vs glimepiride ($3) for T2DM (https://www.ncbi.nlm.nih.gov/pubmed/31536101); semaglutide in T2DM + vascular/CKD (https://www.ncbi.nlm.nih.gov/pubmed/31185157); and whether we should care about pre-diabetes (https://www.ncbi.nlm.nih.gov/pubmed/31076416).
View all episodes
By Mark Ebell
4.7
9292 ratings
A whole lotta diabetes goin' on: linagliptin ($780) vs glimepiride ($3) for T2DM (https://www.ncbi.nlm.nih.gov/pubmed/31536101); semaglutide in T2DM + vascular/CKD (https://www.ncbi.nlm.nih.gov/pubmed/31185157); and whether we should care about pre-diabetes (https://www.ncbi.nlm.nih.gov/pubmed/31076416).
More shows like Primary Care Update
View all
JAMA Editors' Summary
134 Listeners
AFP: American Family Physician Podcast
697 Listeners
JAMA Clinical Reviews
496 Listeners
Mayo Clinic Talks
288 Listeners
GeriPal - A Geriatrics and Palliative Medicine Podcast
298 Listeners
Frankly Speaking About Family Medicine
262 Listeners
The Curbsiders Internal Medicine Podcast
3,340 Listeners
Core IM | Internal Medicine Podcast
1,153 Listeners
Annals On Call Podcast
195 Listeners
JAMA Medical News
85 Listeners
The Clinical Problem Solvers
511 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
363 Listeners
Run the List
248 Listeners
The Curious Clinicians
370 Listeners
The Cribsiders
314 Listeners